This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Radmacher, P. G. Articles by Adamkin, D. H. Search for Related Content PubMed PubMed Citation Articles by Radmacher, P. G. Articles by Adamkin, D. H. Social Bookmarking                         What's this?

Use of the Soluble Peptide -L-Glutamyl-L-Tyrosine to Provide Tyrosine in Total Parenteral Nutrition in Rats

Department of Pediatrics, School of Medicine, University of Louisville

Mary A. Hilton, PHD

Department of Biochemistry, School of Medicine, University of Louisville

Frederick K. Hilton, ScD

Department of Anatomical Sciences and Neurobiology, School of Medicine, University of Louisville

Scott D. Duncan, MD

Department of Pediatrics, School of Medicine, University of Louisville

David H. Adamkin, MD

Department of Pediatrics, School of Medicine, University of Louisville

Limited solubility restricts amounts of tyrosine (Tyr) in amino acid solutions used in total parenteral nutrition (TPN). Excess phenylalanine (Phe) is included in TPN for conversion to Tyr by liver Phe hydroxylase. However, this conversion is limited, especially in infants. We have confirmed that infants receiving TPN have low Tyr concentrations and high Phe/Tyr ratios in plasma compared with published values for enterally fed neonates. Tyr is important in the synthesis of proteins and other biomolecules, including catecholamines in the brain. We tested the soluble peptide -glutamyl-tyrosine (Glu(Tyr)) as a possible precursor of Tyr in TPN. Groups of five rats were given infusions of TPN containing an amino acid mixture simulating a commercial formulation (group A), TPN in which Glu(Tyr) was substituted for half the Phe in the group A solution) (group B), or saline (group C). Control animals (group C) were fed rodent chow. Blood was sampled at 0 time and daily for 4 days. Brains were collected at 96 hours, and aromatic amino acids in plasma and brains were measured by high-performance liquid chromatography. Throughout the experiment, plasma of animals in group A had significantly elevated Phe and reduced Tyr concentrations compared with control values; plasma concentrations in groups B and C were similar. In groups A and B, brain Tyr levels were 31% and 63% of control values, respectively. In group B, Glu(Tyr) was not detected in brains. These data suggest that supplementing current TPN mixtures with Glu(Tyr), which is stable in solution, can produce normal plasma Tyr concentrations and Phe/ Tyr ratios and improve the supply of Tyr to the brain. (Journal of Parenteral and Enteral Nutrition 17:337-344, 1993)

Journal of Parenteral and Enteral Nutrition, Vol. 17, No. 4, 337-344 (1993)
DOI: 10.1177/0148607193017004337


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. Furst A Thirty-Year Odyssey in Nitrogen Metabolism: From Ammonium to Dipeptides JPEN J Parenter Enteral Nutr, July 1, 2000; 24(4): 197 - 209. [PDF]